From structural design to delivery: mRNA therapeutics for cancer immunotherapy
From structural design to delivery: mRNA therapeutics for cancer immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does From structural design to delivery: mRNA therapeutics for cancer immunotherapy have?
From structural design to delivery: mRNA therapeutics for cancer immunotherapy has 106 citations in the OpenAlex counts ScholarIQ stores.
When was From structural design to delivery: mRNA therapeutics for cancer immunotherapy published?
From structural design to delivery: mRNA therapeutics for cancer immunotherapy has 2023 year in the ScholarIQ index.
What is the open-access status of From structural design to delivery: mRNA therapeutics for cancer immunotherapy?
From structural design to delivery: mRNA therapeutics for cancer immunotherapy has gold oa status in the ScholarIQ index.
What is the DOI of From structural design to delivery: mRNA therapeutics for cancer immunotherapy?
The DOI for From structural design to delivery: mRNA therapeutics for cancer immunotherapy is on the source record.
What is the PMID of From structural design to delivery: mRNA therapeutics for cancer immunotherapy?
The PMID for From structural design to delivery: mRNA therapeutics for cancer immunotherapy is on the source record.
What is the OpenAlex record for From structural design to delivery: mRNA therapeutics for cancer immunotherapy?
The OpenAlex for From structural design to delivery: mRNA therapeutics for cancer immunotherapy is on the source record.